FIVE WAYS TO RIDE A WAVE; Human Genome's Tests Could Tell From: The Washington Post | Date: January 10, 2000| Author: Justin Gillis | Copyright 2000 The Washington Post. This material is published under license from the Washington Post.  All inquiries regarding rights should be directed to the Washington Post.Copyright information

A textbook example of a company that is difficult, if not impossible, to value is Human Genome Sciences Inc. of Rockville, a pioneer in using large-scale analysis of human genes in medical research.

The company is widely perceived as being one of the leaders in its field, known as "genomics." It has been in business since 1992, but Human Genome is still in a start-up phase and loses millions every year. It is likely to continue doing so for some time.

That hasn't stopped investor...

Related newspaper, magazine, and journal articles from HighBeam Research

	Federal pact lifts drug firm; Human Genome Sciences sells anthrax treatment.(BUSINESS)(YOUR MONEY: STOCK VIEW) The Washington Times ; Byline: Jen Haberkorn, THE WASHINGTON TIMES Shares of Human Genome Sciences Inc. rose more than 3 percent yesterday after the Rockville drug company announced a contract to supply the federal government with medicine to treat anthrax. Human Genome will supply 10 grams of the drug, ABthrax, to the
	Pfizer deal lifts Human Genome.(BUSINESS)(YOUR MONEY: STOCK VIEW) The Washington Times ; ... Company shares closed on the Nasdaq Stock Market yesterday at $13.08, up 2 percent from a week earlier at $12.78. The deal follows news that Human Genome is laying off 75 workers, or 7 percent of its work force, with redundant job duties. Human Genome is hiring ...
	Glaxo markets diabetes drug by Rockville, Md., biotech Human Genome Sciences. Baltimore Sun (Baltimore, MD) ; ... the newspaper, go to http://www.baltimoresun.com. (c) 2004, The Baltimore Sun. Distributed by Knight Ridder/Tribune Business News. For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-65 ...
	Pfizer Deal Lifts Shares of Rockville, Md.-Based Human Genome Sciences. Knight Ridder/Tribune Business News ; ... Washington Times Knight Ridder/Tribune Business News Dec. 23--Shares of Human Genome Sciences ... week earlier at $12.78. The deal follows news that Human Genome is laying off 75 workers ... Distributed by Knight Ridder/Tribune Business News. HGSI, PFE,
	Rockville, Md.-based Human Genome Sciences plucks CEO from Abbott's ranks. Baltimore Sun (Baltimore, MD) ; Byline: William Patalon III Nov. 23--Human Genome Sciences Inc. yesterday hired a longtime veteran of Abbott Laboratories Inc. as its new chief executive office, the second Maryland biotechnology firm in a week to reach outside the company for new leadership. Rockville-based Human Genome Sciences

See all results.